AXIM BIOTECHNOLOGIES, INC. (AXIM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$505.7K2015: -$10.05M2016: -$3.76M2017: -$3.15M2018: -$5.04M2019: -$3.11M2020: -$4.95M2021: -$13.97M2022: -$4.65M2023: -$2.75M-$2.75M
2014Operating Income (USD)2023
Fiscal YearOperating IncomeChange YoY
2023-$2.75M+40.9%
2022-$4.65M+66.7%
2021-$13.97M-182.4%
2020-$4.95M-59.2%
2019-$3.11M+38.3%
2018-$5.04M-59.9%
2017-$3.15M+16.2%
2016-$3.76M+62.6%
2015-$10.05M-1887.1%
2014-$505.7K